MOLINA HEALTHCARE, INC. (MOH)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

2Y 5Y 10Y All
Quarterly Annual TTM

Revenue Annual

0 20B 40B 60B FY16: 17.8B FY17: 19.9B FY18: 18.9B FY19: 16.8B FY20: 19.4B FY21: 27.8B FY22: 32B FY23: 34.1B FY24: 40.6B FY25: 45.4B FY16 FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25

Gross Profit Annual

0 900M 1.8B 2.7B FY13: 843M FY14: 1B FY15: 1.5B FY16: 1.7B FY17: 1.8B FY18: 2.5B FY19: 2.3B FY20: 2.5B FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20

Operating Income Annual

-600M 0 600M 1.2B 1.8B FY16: 306M FY17: -555M FY18: 1.1B FY19: 1B FY20: 1.1B FY21: 1B FY22: 1.2B FY23: 1.6B FY24: 1.7B FY25: 781M FY16 FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25

Net Income Annual

-1B -500M 0 500M 1B 1.5B FY16: 52M FY17: -512M FY18: 707M FY19: 737M FY20: 673M FY21: 659M FY22: 792M FY23: 1.1B FY24: 1.2B FY25: 472M FY16 FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25

Cost of Revenue Annual

0 15B 30B 45B FY19: 13.9B FY20: 15.8B FY21: 23.7B FY22: 27.2B FY23: 28.7B FY24: 34.4B FY25: 39.5B FY19 FY20 FY21 FY22 FY23 FY24 FY25

Operating Cash Flow Annual

-800M 0 800M 1.6B 2.4B FY16: 673M FY17: 804M FY18: -314M FY19: 434M FY20: 1.9B FY21: 2.1B FY22: 773M FY23: 1.7B FY24: 644M FY25: -535M FY16 FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25

Free Cash Flow Annual

-700M 0 700M 1.4B 2.1B FY16: 497M FY17: 718M FY18: -344M FY19: 377M FY20: 1.8B FY21: 2B FY22: 682M FY23: 1.6B FY24: 544M FY25: -636M FY16 FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25

Operating cash flow minus capital expenditure.

Shares Outstanding Annual

0 25M 50M 75M FY16: 56.2M FY17: 56.4M FY18: 66.6M FY19: 64.2M FY20: 59.9M FY21: 58.6M FY22: 58.5M FY23: 58.1M FY24: 57.7M FY25: 52.9M FY16 FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-16.00 -8.00 0.00 8.00 16.00 24.00 Q4 '15: 2.57 Q1 '16: 2.44 Q2 '16: 2.30 Q3 '16: 2.29 Q4 '16: 0.92 Q1 '17: 1.86 Q2 '17: -2.82 Q3 '17: -5.28 Q4 '17: -9.02 Q1 '18: -8.75 Q2 '18: -1.63 Q3 '18: 2.97 Q4 '18: 10.57 Q1 '19: 11.92 Q2 '19: 11.96 Q3 '19: 11.81 Q4 '19: 11.47 Q1 '20: 11.40 Q2 '20: 12.99 Q3 '20: 13.34 Q4 '20: 11.25 Q1 '21: 12.22 Q2 '21: 10.73 Q3 '21: 10.09 Q4 '21: 11.25 Q1 '22: 11.75 Q2 '22: 12.84 Q3 '22: 14.33 Q4 '22: 13.56 Q1 '23: 14.69 Q2 '23: 15.79 Q3 '23: 16.05 Q4 '23: 18.77 Q1 '24: 18.42 Q2 '24: 18.24 Q3 '24: 19.68 Q4 '24: 20.44 Q1 '25: 20.72 Q2 '25: 20.30 Q3 '25: 16.16 Q4 '16 Q1 '18 Q2 '19 Q3 '20 Q4 '21 Q1 '23 Q2 '24 Q3 '25

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.